clofibric acid has been researched along with Focal Segmental Glomerulosclerosis in 2 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kasiske, BL | 2 |
| O'Donnell, MP | 2 |
| Garvis, WJ | 1 |
| Keane, WF | 2 |
2 other studies available for clofibric acid and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure.
Topics: Animals; Cholesterol; Clofibrate; Clofibric Acid; Disease Models, Animal; Glomerulonephritis; Glomer | 1988 |
The role of lipids in progressive glomerular disease.
Topics: Animals; Clofibric Acid; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Humans; Hyperlipid | 1987 |